Rafaèle Tordjman is the Founder & CEO of Jeito Capital, a global independent Private Equity fund dedicated to investing in and supporting promising biopharma companies. The fund aims to accelerate the development of breakthrough innovations for patients. In September 2021, Jeito I successfully raised €534 million ($630 million).